Analyst firms · Piper Sandler · TER
Piper Sandler TER price target and rating history
Teradyne Inc. (TER) · Industrials
Piper Sandler rates Teradyne Inc. (TER) Overweight with a $163 price target, as of its latest action on Jan 28, 2022. It has published 4 rating actions on TER since October 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a TER price target in the last 12 months, the median target is $277.
- Current rating
- Overweight
- Price target
- $163
- Median target, all firms
- $277
- Actions on TER
- 4
Piper Sandler price target on TER
Every Piper Sandler rating on TER
- Jan 28, 2022
- Dec 15, 2021
- Nov 15, 2021
- Oct 15, 2021
How other firms rate TER
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $284 | Nov 11, 2026 |
| Robert W. Baird | Neutral | $420 | Aug 21, 2026 |
| Goldman Sachs | Buy | $465 | Jul 6, 2026 |
| Northland Capital Markets | Market Perform | $270 | Feb 4, 2026 |
| Vertical Research | Hold | $220 | Jan 9, 2026 |
| Stifel | Buy | $225 | Dec 2, 2025 |
Questions about Piper Sandler and TER
- What is Piper Sandler's price target for TER?
- Piper Sandler's latest stated price target for Teradyne Inc. (TER) is $163, from its action on Jan 28, 2022.
- What is Piper Sandler's rating on TER?
- Piper Sandler rates TER Overweight, a bullish rating, as of Jan 28, 2022.
- When did Piper Sandler last change its view on TER?
- On Jan 28, 2022, Piper Sandler cuts its price target to $163 from $173, keeps Overweight.
- How does Piper Sandler's TER target compare with other analysts?
- Across 6 firms with a TER price target in the last 12 months, the median target is $277.
More TER rating histories
- Goldman Sachs6
- Northland Capital Markets4
- BofA Securities4
- Susquehanna3
- Morgan Stanley6
- KeyBanc Capital Markets3
- TD Cowen3
- Craig-Hallum5
- J.P. Morgan3
All Piper Sandler ratingsTER news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.